Gerd Kochendoerfer, Ph.D.
Chief Operating Officer
Gerd joined atai as Chief Operating Officer in 2024, bringing over 25 years of experience in leadership roles across the pharmaceutical and biotech sectors. He has a strong track record in drug development, corporate development, and team leadership. Gerd leads atai’s development and business operations, and quality infrastructure.
Gerd holds a Ph.D. in Chemistry from UC Berkeley, is an inventor on multiple patents and has published more than 25 papers in peer-reviewed literature.
Senior Leadership
Srinivas Rao, M.D., Ph.D.
Co-Founder and Chief Executive Officer
Anne Johnson
Chief Financial Officer
Gerd Kochendoerfer, Ph.D.
Chief Operating Officer
Robert Conley, M.D.
Chief Research and Development Officer
Kevin Craig, M.D.
Chief Medical Officer
Glenn Short, Ph.D.
Chief Scientific Officer
Ryan Barrett
Chief Legal and Business Officer
Board of Directors
Srinivas Rao, M.D., Ph.D.
Co-Founder and Chief Executive Officer
Christian Angermayer
Founder and Chairman
Scott Braunstein, M.D.
Vice Chairman and Lead Independent Director Science and Technology Committee, Chair Audit Committee, Member
Cosmo Feilding Mellen
Co-Founder and Director
Laurent Fischer, M.D.
Director Science and Technology Committee, Member Compensation Committee, Member
Rob Hershberg, M.D., Ph.D.
Board member
Andrea Heslin Smiley
Director Compensation Committee, Chair Nominating and Corporate Governance Committee, Member Audit Committee, Member
John Hoffman
Director
Amir Kalali, M.D.
Director Science and Technology Committee, Member Audit Committee, Member
Sabrina Martucci Johnson
Director Audit Committee, Chair Nominating and Corporate Governance Committee, Chair
